Form 4: Lifeway Foods Director Jason Scher Acquires Phantom Stock Through Deferred Compensation

Director Jason Scher acquired 878 shares of phantom stock in Lifeway Foods through deferred compensation for board service in the quarter ending September 30, 2024.

Summary

• On September 30, 2024, Jason Scott Scher, a director of Lifeway Foods, Inc., acquired 878 shares of phantom stock.
• This acquisition was a result of deferring cash compensation for his service on the Board of Directors for the quarter ended September 30, 2024.
• Scher directly owns 24,567 shares of Lifeway Foods common stock.
• He also holds restricted stock units (RSUs) that will vest on various dates in the future, contingent on his continued service as a director.
• The phantom stock becomes payable when Scher no longer serves as a director of the company.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine transaction related to director compensation. The director's decision to defer compensation into phantom stock could be seen as a positive signal, but it's not a major event.

Positives

• Director's continued investment in the company through deferred compensation shows confidence.
• The vesting of RSUs is tied to continued service, aligning director's interests with the company's long-term success.

Risks

• The value of the phantom stock and RSUs is tied to the performance of Lifeway Foods' common stock, which is subject to market fluctuations.
• The vesting of RSUs is contingent on continued service as a director, creating a potential risk if Scher were to leave the board.

Future Outlook

The phantom stock becomes payable when the Reporting Person no longer serves as a director of the Company. The RSUs vest on future dates contingent on continued service.

Industry Context

Directors often receive stock-based compensation to align their interests with shareholders. Deferring cash compensation into phantom stock is a common practice.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates